111 related articles for article (PubMed ID: 8464387)
1. [Aromatase inhibitor].
Stein M
Med Monatsschr Pharm; 1993 Mar; 16(3):66-7. PubMed ID: 8464387
[No Abstract] [Full Text] [Related]
2. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
3. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
Santen RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
[No Abstract] [Full Text] [Related]
4. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
[TBL] [Abstract][Full Text] [Related]
5. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
Harris AL
Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
[TBL] [Abstract][Full Text] [Related]
6. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
7. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Friedrichs K; Jänicke F
Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
[TBL] [Abstract][Full Text] [Related]
8. Aromatase, its inhibitors and their use in breast cancer treatment.
Brodie AM
Pharmacol Ther; 1993 Dec; 60(3):501-15. PubMed ID: 8073072
[TBL] [Abstract][Full Text] [Related]
9. Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide.
Bezwoda WR; Mansoor N; Dansey R
Oncology; 1987; 44(6):345-9. PubMed ID: 3684175
[TBL] [Abstract][Full Text] [Related]
10. Interactions of antioestrogens and aromatase inhibitors.
Schmid P; Possinger K
Forum (Genova); 2002; 12(1):45-59. PubMed ID: 12634910
[TBL] [Abstract][Full Text] [Related]
11. [Hormone therapy of metastatic breast carcinoma].
Höffken K; Miller AA; Miller B; Becher R; Schmidt CG
Dtsch Med Wochenschr; 1985 Nov; 110(47):1799-802. PubMed ID: 3933941
[No Abstract] [Full Text] [Related]
12. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
[TBL] [Abstract][Full Text] [Related]
13. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
14. A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.
Younus J; Vandenberg TA
Bull Cancer; 2005 Apr; 92(4):E39-44. PubMed ID: 15888383
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
16. Optimal sequence of hormonotherapy in advanced breast cancer.
Bertelli G; Paridaens R
Curr Opin Oncol; 2006 Nov; 18(6):572-7. PubMed ID: 16988577
[TBL] [Abstract][Full Text] [Related]
17. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
Foster PA; Chander SK; Newman SP; Woo LW; Sutcliffe OB; Bubert C; Zhou D; Chen S; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2008 Oct; 14(20):6469-77. PubMed ID: 18927286
[TBL] [Abstract][Full Text] [Related]
18. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors as potential cancer chemopreventives.
Kelloff GJ; Lubet RA; Lieberman R; Eisenhauer K; Steele VE; Crowell JA; Hawk ET; Boone CW; Sigman CC
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):65-78. PubMed ID: 9456245
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal treatment of breast tumor].
Garcia Giralt E; Omodei Zorini C
Clin Ter; 1990 Feb; 132(4):217-27. PubMed ID: 2140308
[No Abstract] [Full Text] [Related]
[Next] [New Search]